Allergan Plc (AGN) - Financial and Strategic SWOT Analysis Review

Allergan Plc (AGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:


- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology, women’s health, urology and anti-infective therapeutic categories. The company sells its products to retailers, drug wholesalers and distributors, including national retail drug and food store chains, mail order retailers, hospitals, clinics, government agencies and managed healthcare providers such as health maintenance organizations and other institutions. It has operations across the Americas, Europe, Asia-Pacific, the Middle East and Africa. Allergan is headquartered in Dublin, Ireland.

Allergan Plc Key Recent Developments

Apr 02,2020: Others : China Gives Greenlight to Allergans XEN Registration for the Surgical Management of Refractory Glaucoma
Mar 30,2020: The Allergan Foundation donates $2.0 million to community organizations on front-line of covid-19 response
Mar 26,2020: Allergan and Bausch Health identified as the top companies driving therapeutic innovation in IBS
Mar 17,2020: AbbVie and Allergan Sign Consent Decree Agreement with Federal Trade Commission Staff on Pending Transaction
Mar 05,2020: Others : Prescribing Information, including Boxed Warnings

Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 


Section 1 - About the Company
Allergan Plc - Key Facts
Allergan Plc - Key Employees
Allergan Plc - Key Employee Biographies
Allergan Plc - Major Products and Services
Allergan Plc - History
Allergan Plc - Company Statement
Allergan Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Allergan Plc - Business Description
Business Segment: International Brands Segment
Overview
Performance
Business Segment: US General Medicine Segment
Overview
Performance
Business Segment: US Specialized Therapeutics Segment
Overview
Performance
R&D Overview
Allergan Plc - Corporate Strategy
Allergan Plc - SWOT Analysis
SWOT Analysis - Overview
Allergan Plc - Strengths
Allergan Plc - Weaknesses
Allergan Plc - Opportunities
Allergan Plc - Threats
Allergan Plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Allergan Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 30, 2020: The Allergan Foundation donates $2.0 million to community organizations on front-line of covid-19 response
Mar 26, 2020: Allergan and Bausch Health identified as the top companies driving therapeutic innovation in IBS
Feb 10, 2020: Allergan reports fourth quarter and full-year 2019 financial results
Jan 29, 2020: Allergan opens new biologics facility in Westport, Ireland
Jan 27, 2020: AbbVie and Allergan to sell brazikumab and Zenpep
Jan 17, 2020: SkinMedica launches new instant bright eye cream for immediate, visible results
Jan 06, 2020: Allergan units resolve antitrust litigation on Loestrin 24 Fe and Minastrin 24 Fe
Nov 05, 2019: Allergan reports third quarter 2019 financial results
Oct 16, 2019: Allergan shareholders approve $63bn Abbvie acquisition
Oct 10, 2019: On World Sight Day, Allergan launches national campaign to raise awareness of the toll glaucoma takes on everyday living
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
 


List Of Tables


Allergan Plc, Key Facts
Allergan Plc, Key Employees
Allergan Plc, Key Employee Biographies
Allergan Plc, Major Products and Services
Allergan Plc, History
Allergan Plc, Other Locations
Allergan Plc, Subsidiaries
Allergan Plc, Key Competitors
Allergan Plc, Ratios based on current share price
Allergan Plc, Annual Ratios
Allergan Plc, Annual Ratios (Cont...1)
Allergan Plc, Annual Ratios (Cont...2)
Allergan Plc, Interim Ratios
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Allergan Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures


Allergan Plc, Performance Chart (2015 - 2019)
Allergan Plc, Ratio Charts
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Allergan Plc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
 


Ophthalmology Drugs Global Market Forecast To 2022 Including: Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy) Covering: Novartis AG, F. Hoffmann-La Roche Ltd, Allergan Plc, Valeant Pharmaceuticals Intl Inc, Bayer AG

The ophthalmology drugs market consists of sales of ophthalmology drugs and related services by entities (organizations, sole traders and partnerships) that produce ophthalmology drugs to treat eye related diseases. This

USD 4000 View Report

Gastrointestinal Drugs Global Market Forecast To 2022 Including: Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals Covering: Takeda Pharmaceticals, Allergan Plc, Novo Nordisk A/S, AstraZeneca Plc, Johnson & Johnson

The gastrointestinal drugs market consists of sales of gastrointestinal drugs and related services by entities (organizations, sole traders and partnerships) that produce gastrointestinal drugs to treat gastrointestinal diseases. This industry

USD 4000 View Report

Ophthalmology Drugs Global Market Forecast To 2022 Including: Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy) Covering: Novartis AG, F. Hoffmann-La Roche Ltd, Allergan Plc, Valeant Pharmaceuticals Intl Inc, Bayer AG

The ophthalmology drugs market consists of sales of ophthalmology drugs and related services by entities (organizations, sole traders and partnerships) that produce ophthalmology drugs to treat eye related diseases. This

USD 4000 View Report

Gastrointestinal Drugs Global Market Forecast To 2022 Including: Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals Covering: Takeda Pharmaceticals, Allergan Plc, Novo Nordisk A/S, AstraZeneca Plc, Johnson & Johnson

The gastrointestinal drugs market consists of sales of gastrointestinal drugs and related services by entities (organizations, sole traders and partnerships) that produce gastrointestinal drugs to treat gastrointestinal diseases. This industry

USD 4000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available